Obesity More Prevalent in Survivors, Especially Those Who Had Breast or Colorectal Cancer
August 25th 2016A large, population-based study found that obesity more prevalent in patients with a history of cancer than in the general population, suggesting an important area of focus and a need for improved weight management and control programs targeted at survivors’ specific needs.
CINV Treatment Sustol Approved by FDA
August 10th 2016An extended-release injection formulation of granisetron (Sustol) has been approved by the FDA for use in combination with other antiemetic therapies for the prevention of CINV, according to the manufacturer of the treatment, Heron Therapeutics.
More Evidence That Health Insurance Status Affects Survival of Patients With Cancer
August 10th 2016Patients with cancer who have Medicaid coverage or who are uninsured are more likely to be diagnosed later and receive improper treatment for cancer, according to two recent studies, and these factors can have an impact on their survival.
Practice Guideline Enhances Role for Neoadjuvant Chemotherapy in Ovarian Cancer
August 10th 2016While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and interval cytoreduction.